CMVLF (Cellectis) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CMVLF Cellectis SA CMVLF
59 GF Score
Price $3.47
GF Value $4.04
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Cellectis Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

CMVLF
59GF Score
Cellectis SA CMVLF
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cellectis (CMVLF) Overvalued in 2026?

Based on GuruFocus' analysis, Cellectis stock appears to be undervalued. The current stock price of $3.47 is trading 14.1% below its estimated GF Value™ of $4.04. GuruFocus considers Cellectis to be Modestly Undervalued.

Key valuation signals for CMVLF:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $4.04 vs. price of $3.47 (14.1% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the CMVLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cellectis Business Description

Address 8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
59GF Score

Get the complete analysis for CMVLF

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.47
Price
$4.04
GF Value